Safwat Albert Gassis MD FACC, FHRS, MMM, CPE
Cardiac Electrophysiology
Cardiac Electrophysiology Cardiology Physician Lead PennState Health Holy Spirit and Hampden Medical Centers Director, Atrial Fibrillation Center
Join to View Full Profile
875 Poplar Church Rdsuite 400Camp Hill, PA 17011
Phone+1 717-724-6450
Fax+1 717-724-6451
Dr. Gassis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
American Association of Physician LeadershipCPE, Certified Physician Executive, 2019 - 2020- Carnegie Mellon UniversityMMM, Master of Medical Management, 2015 - 2018
Emory University School of MedicineFellowship, Clinical Cardiac Electrophysiology, 2004 - 2006- Emory University School of MedicineFellowship, Cardiovascular Disease, 2002 - 2004
- Emory University School of MedicineResidency, Internal Medicine, 1999 - 2002
Georgetown University School of MedicineClass of 1999
Certifications & Licensure
PA State Medical License 2006 - 2026
GA State Medical License 2002 - 2009
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
Publications & Presentations
PubMed
- 6 citationsProgress in cardiovascular disease: technical considerations in cardiac resynchronization therapy.Safwat A. Gassis, David B. Delurgio, Angel R. Leon
Progress in Cardiovascular Diseases. 2006-01-01 - 6 citationsCardiac resynchronization therapy: strategies for device programming, troubleshooting and follow-up.Safwat A. Gassis, Angel R. Leon
Journal of Interventional Cardiac Electrophysiology. 2005-09-01 - 36 citationsFrequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance.Safwat Gassis, Pradipsinh K. Rathod
Antimicrobial Agents and Chemotherapy. 1996-04-01
Press Mentions
Three Penn State Health Hospitals Introduce New Technology for Treatment of Atrial FibrillationJune 24th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
